The future of drug development

Medicines are becoming increasingly complex and therefore require new skills, new capacities and, to some extent, new interpretation of the regulatory framework. What are the needs, what opportunities do we see and how well equipped are we? Against this background, RISE and Lif invite you to a morning with the aim of highlighting the area and discussing what is needed.

From the program

  • Jenni Nordborg, Life Science Coordinator, Government Offices of Sweden.
  • Two blocks with subsequent panel discussions following presentations from a wide range of companies and authorities related to the future of medicines.

Read more and register here.